GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Other Long-Term Liabilities

HLB Science (XKRX:343090) Other Long-Term Liabilities : ₩0.00 Mil (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science Other Long-Term Liabilities?

HLB Science's other long-term liabilities for the quarter that ended in . 20 was ₩0.00 Mil.

HLB Science's annual other long-term liabilities increased from . 20 (₩0.00 Mil) to Dec. 2022 (₩47.02 Mil) and increased from Dec. 2022 (₩47.02 Mil) to Dec. 2023 (₩767.08 Mil).


HLB Science Other Long-Term Liabilities Historical Data

The historical data trend for HLB Science's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Other Long-Term Liabilities Chart

HLB Science Annual Data
Trend Dec22 Dec23
Other Long-Term Liabilities
- -

HLB Science Quarterly Data
Other Long-Term Liabilities

HLB Science Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


HLB Science Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of HLB Science's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Science (XKRX:343090) Business Description

Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines